BDBM403491 US10335399, Example 4-1B::US10806724, Example 4-1B

SMILES CN(C[C@@H]1CCc2c(O1)nc(cc2-c1ccc(F)cc1F)C(N)=O)CC(F)(F)F

InChI Key InChIKey=QCVOOLBKUHWWQR-NSHDSACASA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 403491   

TargetMetabotropic glutamate receptor 2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM403491(US10335399, Example 4-1B | US10806724, Example 4-1...)
Affinity DataIC50:  74nMAssay Description:The utility of the compounds of the invention as an inhibitor of metabotropic glutamate receptor activity, in particular mGluR2 activity, may be demo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMetabotropic glutamate receptor 2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM403491(US10335399, Example 4-1B | US10806724, Example 4-1...)
Affinity DataIC50:  74nMAssay Description:The utility of the compounds of the invention as an inhibitor of metabotropic glutamate receptor activity, in particular mGluR2 activity, may be demo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent